Are preoperative examinations useful in the management of patients with renal hyperparathyroidism?

被引:11
作者
Guillem, P
Vlaeminck-Guillem, V
Dracon, A
Noel, C
Cussac, JF
Huglo, D
Proye, C
机构
[1] CHRU Lille, Hop Huriez, Serv Chirurg Gen & Endocrinienne, F-59037 Lille, France
[2] CHRU Lille, Clin Endocrinol Marc Linquette, F-59037 Lille, France
[3] CHRU Lille, Clin Nephrol A & B, Hop Calmette, F-59037 Lille, France
[4] CHRU Lille, Serv Cent Radiol, Hop Huriez, F-59037 Lille, France
[5] CHRU Lille, Nucl Med Serv, Hop Huriez, F-59037 Lille, France
来源
ANNALES DE CHIRURGIE | 2006年 / 131卷 / 01期
关键词
hyperparathyroidism; renal failure; ultrasonography; scintigraphy; sesta-MIBI; surgery;
D O I
10.1016/j.anchir.2005.10.013
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aim of the study: To evaluate the efficiency of preoperative parathyroid ultrasonography and scintigraphy in the management of renal hyperparathyroidism. Patients and methods: The charts of the last consecutive 200 patients who underwent surgery for renal hyperparathyroidism from 1998 to 2003 were retrospectively reviewed to collect data concerning parathyroid gland function, results of preoperative ultrasonography and scintigraphy, as well as modalities and results of surgical exploration. Results: Ultrasonography and scintigraphy sensibilities were 36.4% and 49.3%, respectively. Efficiency of both examinations was improved when they were combined (sensibility of 64.7%) and in those patients managed for recurrent hyperparathyroidism. Were more often detected by preoperative examinations glands with high weight and/or greatest diameter, orthotopic and inferior glands as well as glands exhibiting nodular hyperplasia content upon pathological examination. Conclusion: Parathyroid ultrasonography and scintigraphy are of poor interest in the management of renal hyperparathyroidism. In a preoperative setting, they should be performed only in patients with recurrent disease. (c) 2005 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 26 条
[1]   Supernumerary parathyroid glands in recurrent secondary hyperparathyroidism [J].
Arveschoug, AK ;
Brochner-Mortensen, J ;
Bertelsen, H ;
Vammen, B .
CLINICAL NUCLEAR MEDICINE, 2002, 27 (08) :599-601
[2]  
Arveschoug AK, 2002, CLIN NUCL MED, V27, P249
[3]  
Carpentier A, 1998, J NUCL MED, V39, P1441
[4]  
Chen H, 2003, ANN SURG, V238, P332, DOI 10.1097/01.sla.0000086546.68794.9a
[5]   TC-99M SESTAMIBI - A NEW AGENT FOR PARATHYROID IMAGING [J].
COAKLEY, AJ ;
KETTLE, AG ;
WELLS, CP ;
ODOHERTY, MJ ;
COLLINS, REC .
NUCLEAR MEDICINE COMMUNICATIONS, 1989, 10 (11) :791-794
[6]   A genome-wide analysis of transcriptional effect of Gal11 in Saccharomyces cerevisiae:: An application of "Mini-array hybridization technique" [J].
Fukasawa, T ;
Fukuma, M ;
Yano, K ;
Sakurai, H .
DNA RESEARCH, 2001, 8 (01) :23-31
[7]   The embryology of the parathyroid glands, the thymus and certain associated rudiments [J].
Gilmour, JR .
JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1937, 45 (03) :507-522
[8]   In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria [J].
Hetrakul, N ;
Civelek, C ;
Stagg, CA ;
Udelsman, R .
SURGERY, 2001, 130 (06) :1011-1018
[9]   Parathyroid gland radionuclide scanning -: methods and indications [J].
Hindié, E ;
de Labriolle-Vaylet, C ;
Mellière, D ;
Jeanguillaume, C ;
Urena, P ;
Perlemuter, L ;
Askienazy, S .
JOINT BONE SPINE, 2002, 69 (01) :28-36
[10]   RETRACTED: Size and P-glycoprotein expression limit 99mTc-tetrofosmin uptake in parathyroid adenomas (Retracted Article. See vol 29, 2008) [J].
Huang, WT .
NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (10) :1001-1004